Valuation: Gedeon Richter

Market Cap 2,231B 6.82B 6.06B 5.66B 5.16B 9.72B 656B 9.81B 68.46B 26.53B 335B 25.61B 25.06B 1,076B P/E 2026 *
9x
P/E 2027 * 7.7x
Enterprise Value 1,968B 6.02B 5.35B 4.99B 4.55B 8.58B 579B 8.66B 60.4B 23.41B 296B 22.6B 22.11B 949B EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.78x
Free-Float
72.87%
Yield 2026 *
4.94%
Yield 2027 * 5.54%
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 2017-10-31
Director of Finance/CFO - 2025-04-30
Chief Operating Officer - 2018-12-31
Director TitleAgeSince
Chairman 79 2016-12-31
Chairman 90 2024-02-29
Director/Board Member 65 2012-04-25
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 6.9B
-0.61%-3.43%+39.40%+112.31% 1,025B
-1.02%-5.60%+37.67%+65.02% 623B
+1.11%-0.58%+11.10%+77.28% 459B
+0.34%-3.01%+61.21%+40.71% 355B
-0.95%-4.05%+21.60%+39.37% 336B
-1.46%-2.89%+11.84%+24.60% 270B
-1.35%-5.43%-4.69%+8.40% 247B
-1.04%-2.79%+35.52%+51.34% 220B
-1.87%-4.10%+30.92%+95.33% 183B
Average +2.23%-3.15%+27.17%+57.15% 413.14B
Weighted average by Cap. +0.46%-3.17%+30.51%+68.92%

Financials

2026 *2027 *
Net sales 951B 2.91B 2.58B 2.41B 2.2B 4.15B 280B 4.19B 29.2B 11.31B 143B 10.92B 10.69B 459B 1,021B 3.12B 2.77B 2.59B 2.36B 4.45B 300B 4.49B 31.33B 12.14B 153B 11.72B 11.47B 492B
Net income 254B 778M 691M 645M 588M 1.11B 74.76B 1.12B 7.8B 3.02B 38.22B 2.92B 2.86B 123B 291B 889M 789M 737M 672M 1.27B 85.42B 1.28B 8.92B 3.46B 43.67B 3.34B 3.26B 140B
Net Debt -262B -803M -713M -666M -607M -1.14B -77.16B -1.15B -8.06B -3.12B -39.45B -3.01B -2.95B -127B -410B -1.25B -1.11B -1.04B -948M -1.79B -121B -1.8B -12.58B -4.88B -61.62B -4.71B -4.61B -198B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,230.00HUF
Average target price
13,214.57HUF
Spread / Average Target
+8.05%

Quarterly revenue - Rate of surprise